MENU
AIM
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AIM ImmunoTech (AIM) Ownership - Who owns AIM ImmunoTech?
Profile
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.43M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
3.35M
Revenue
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
AIM
Capitalization
13.4M
P/E Ratio
N/A
Risk (Beta)
1.32
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
3.35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
N/A
ROE
N/A
Book Value
4.14M
P/B Ratio
4.61
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
50K
Current Ratio
1.14
Current Revenue Per Employee
1428.57
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
80.00
Revenue To Assets
N/A
Shares Held By Institutions
3.75M
Shares Outstanding - Current
63.8M
Total Liabilities
11.4M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-52.148
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2117 SW Highway 484
Phone
+1 352 448-7797
Employees
28
Web
https://www.aimimmuno.com